Optimum therapy for essential hypertension.
D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000150:complications; D001341:Autonomic Nervous System / Q000187:drug effects / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects; D002740:Chlorothiazide / Q000627:therapeutic use; D004035:Diet Therapy; D004232:Diuretics / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000378:metabolism / Q000628:therapy*; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007677:Kidney Function Tests; D008750:Methyldopa / Q000627:therapeutic use; D009538:Nicotine; D009638:Norepinephrine / Q000627:therapeutic use; D009765:Obesity / Q000517:prevention & control; D012907:Smoking; D012964:Sodium / Q000378:metabolism; D013315:Stress, Psychological / Q000503:physiopathology; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000959:Antihypertensive Agents; D004232:Diuretics; D006993:Hypnotics and Sedatives; D014149:Tranquilizing Agents; D008750:Methyldopa; D009538:Nicotine; D002740:Chlorothiazide; D012964:Sodium; D009638:Norepinephrine; D006145:Guanethidine